肺部恶性肿瘤手术隔离技术专家共识

2020-09-30 0 中华护理杂志.2020.55(9):1-6.

《共识》包括手术护理人员资质、术前评估、手术设备和仪器、切口的保护、手术体腔探查、器械敷料管理、肿瘤的切除、肿瘤的取出、同期手术与重建手术、冲洗液的使用、物品清点等11个方面的内容,适用于传统开放手术

中文标题:

肺部恶性肿瘤手术隔离技术专家共识

发布机构:

0

发布日期:

2020-09-30

简要介绍:

《共识》包括手术护理人员资质、术前评估、手术设备和仪器、切口的保护、手术体腔探查、器械敷料管理、肿瘤的切除、肿瘤的取出、同期手术与重建手术、冲洗液的使用、物品清点等11个方面的内容,适用于传统开放手术、小切口手术及胸腔镜手术等。结论《共识》从肺部手术的肿瘤隔离技术出发,针对各环节制订了详细的操作规范,易于手术护理人员执行,能够指导临床实践。

相关资料下载:
[AttachmentFileName(sort=1, fileName=肺部恶性肿瘤手术隔离技术专家共识_魏永婷.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f1bc01c00200696a, title=肺部恶性肿瘤手术隔离技术专家共识, enTitle=, guiderFrom=中华护理杂志.2020.55(9):1-6., authorId=0, author=, summary=《共识》包括手术护理人员资质、术前评估、手术设备和仪器、切口的保护、手术体腔探查、器械敷料管理、肿瘤的切除、肿瘤的取出、同期手术与重建手术、冲洗液的使用、物品清点等11个方面的内容,适用于传统开放手术, cover=https://img.medsci.cn/20201110/1605018944329_2020535.jpg, journalId=0, articlesId=null, associationId=null, associationName=0, associationIntro=, copyright=0, guiderPublishedTime=Wed Sep 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>《共识》包括手术护理人员资质、术前评估、手术设备和仪器、切口的保护、手术体腔探查、器械敷料管理、肿瘤的切除、肿瘤的取出、同期手术与重建手术、冲洗液的使用、物品清点等11个方面的内容,适用于传统开放手术、小切口手术及胸腔镜手术等。结论《共识》从肺部手术的肿瘤隔离技术出发,针对各环节制订了详细的操作规范,易于手术护理人员执行,能够指导临床实践。</p> </div> </div> </div>, tagList=[TagDto(tagId=107973, tagName=肺部恶性肿瘤)], categoryList=[CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=17365, guiderKeyword=肺癌手术, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=27337, appHits=132, showAppHits=0, pcHits=883, showPcHits=27205, likes=1, shares=7, comments=8, approvalStatus=1, publishedTime=Tue Nov 10 23:11:31 CST 2020, publishedTimeString=2020-09-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Nov 10 22:35:53 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:24:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=肺部恶性肿瘤手术隔离技术专家共识_魏永婷.pdf)])
肺部恶性肿瘤手术隔离技术专家共识_魏永婷.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1005540, encodeId=9f8c10055403d, content=(O∆O)(❤ε❤), beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0845519547, createdName=ZP-1883, createdTime=Fri Aug 06 08:26:41 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005539, encodeId=57ec10055394a, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0845519547, createdName=ZP-1883, createdTime=Fri Aug 06 08:26:22 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912072, encodeId=5c839120e2ab, content=太好啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/2c39f40f0e7e4e4db6a244796eccfea0/f463a17bc61a4f8b8edbbb1e406212f4.jpg, createdBy=e16c5448684, createdName=ms8000001231068827, createdTime=Wed Dec 30 06:56:36 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903856, encodeId=a98790385621, content=真的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aac5438886, createdName=ms8000002012625629, createdTime=Tue Dec 01 13:28:03 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898395, encodeId=8bbc8983950a, content=真好,值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/6ea5abada2334aabb2737efec80d0f14/16a8a75d63a842369f74b14d4c0fcf86.jpg, createdBy=a8555433340, createdName=春江水暖, createdTime=Wed Nov 11 08:21:28 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2021-08-06 ZP-1883

    (O∆O)(❤ε❤)

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1005540, encodeId=9f8c10055403d, content=(O∆O)(❤ε❤), beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0845519547, createdName=ZP-1883, createdTime=Fri Aug 06 08:26:41 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005539, encodeId=57ec10055394a, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0845519547, createdName=ZP-1883, createdTime=Fri Aug 06 08:26:22 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912072, encodeId=5c839120e2ab, content=太好啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/2c39f40f0e7e4e4db6a244796eccfea0/f463a17bc61a4f8b8edbbb1e406212f4.jpg, createdBy=e16c5448684, createdName=ms8000001231068827, createdTime=Wed Dec 30 06:56:36 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903856, encodeId=a98790385621, content=真的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aac5438886, createdName=ms8000002012625629, createdTime=Tue Dec 01 13:28:03 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898395, encodeId=8bbc8983950a, content=真好,值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/6ea5abada2334aabb2737efec80d0f14/16a8a75d63a842369f74b14d4c0fcf86.jpg, createdBy=a8555433340, createdName=春江水暖, createdTime=Wed Nov 11 08:21:28 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2021-08-06 ZP-1883

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1005540, encodeId=9f8c10055403d, content=(O∆O)(❤ε❤), beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0845519547, createdName=ZP-1883, createdTime=Fri Aug 06 08:26:41 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005539, encodeId=57ec10055394a, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0845519547, createdName=ZP-1883, createdTime=Fri Aug 06 08:26:22 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912072, encodeId=5c839120e2ab, content=太好啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/2c39f40f0e7e4e4db6a244796eccfea0/f463a17bc61a4f8b8edbbb1e406212f4.jpg, createdBy=e16c5448684, createdName=ms8000001231068827, createdTime=Wed Dec 30 06:56:36 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903856, encodeId=a98790385621, content=真的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aac5438886, createdName=ms8000002012625629, createdTime=Tue Dec 01 13:28:03 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898395, encodeId=8bbc8983950a, content=真好,值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/6ea5abada2334aabb2737efec80d0f14/16a8a75d63a842369f74b14d4c0fcf86.jpg, createdBy=a8555433340, createdName=春江水暖, createdTime=Wed Nov 11 08:21:28 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2020-12-30 ms8000001231068827

    太好啦

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1005540, encodeId=9f8c10055403d, content=(O∆O)(❤ε❤), beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0845519547, createdName=ZP-1883, createdTime=Fri Aug 06 08:26:41 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005539, encodeId=57ec10055394a, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0845519547, createdName=ZP-1883, createdTime=Fri Aug 06 08:26:22 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912072, encodeId=5c839120e2ab, content=太好啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/2c39f40f0e7e4e4db6a244796eccfea0/f463a17bc61a4f8b8edbbb1e406212f4.jpg, createdBy=e16c5448684, createdName=ms8000001231068827, createdTime=Wed Dec 30 06:56:36 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903856, encodeId=a98790385621, content=真的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aac5438886, createdName=ms8000002012625629, createdTime=Tue Dec 01 13:28:03 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898395, encodeId=8bbc8983950a, content=真好,值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/6ea5abada2334aabb2737efec80d0f14/16a8a75d63a842369f74b14d4c0fcf86.jpg, createdBy=a8555433340, createdName=春江水暖, createdTime=Wed Nov 11 08:21:28 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2020-12-01 ms8000002012625629

    真的很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1005540, encodeId=9f8c10055403d, content=(O∆O)(❤ε❤), beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0845519547, createdName=ZP-1883, createdTime=Fri Aug 06 08:26:41 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005539, encodeId=57ec10055394a, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0845519547, createdName=ZP-1883, createdTime=Fri Aug 06 08:26:22 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912072, encodeId=5c839120e2ab, content=太好啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/2c39f40f0e7e4e4db6a244796eccfea0/f463a17bc61a4f8b8edbbb1e406212f4.jpg, createdBy=e16c5448684, createdName=ms8000001231068827, createdTime=Wed Dec 30 06:56:36 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903856, encodeId=a98790385621, content=真的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aac5438886, createdName=ms8000002012625629, createdTime=Tue Dec 01 13:28:03 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898395, encodeId=8bbc8983950a, content=真好,值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/6ea5abada2334aabb2737efec80d0f14/16a8a75d63a842369f74b14d4c0fcf86.jpg, createdBy=a8555433340, createdName=春江水暖, createdTime=Wed Nov 11 08:21:28 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2020-11-11 春江水暖

    真好,值得一看

    0

拓展阅读

EACR多学科团队共识:术前无组织学诊断情况下的肺癌切除

欧洲癌症研究协会(EACR,European Association for Cancer Research) · 2023-04-15